Using single-cell multiome analysis and extensive chromatin profiling, we reveal that much transcriptional heterogeneity in KMT2A::AFF1 ALL is driven by novel enhancer usage. The gene discussed is AFF1; the disease is acute lymphoblastic leukemia.